A therapeutic virus against cancer Fusix Biotech, a spin-off from the Technical University of Munich (TUM) develops virus-based cancer therapies that mobilize the body’s own immune defenses.

Jennifer Altomonte and her team at Fusix Biotech, a spin-off from our university, are developing virus-based #cancertherapies that mobilize the body’s own #immunedefenses in the fight against the disease: go.tum.de/312166

#ImmunoTherapy

📷J. Eberle